Daymark's scope includes diagnostic workups and continuous in-home and virtual cancer care; OncoHealth's Iris is a virtual supportive-care service, so buyer fit depends on whether a plan needs diagnostic workup and home delivery. Daymark Clarity expedites workups with patient education and management of testing, imaging, biopsies, and prior authorizations, and OncoHealth's Iris provides access to oncology-trained nurses, mental-health therapists, and dietitians.

Daymark's care model addresses both clinical and non-clinical cancer-care needs. The 2026 BCBSRI report linked Daymark's payer program with lower admissions and spending.

Oncology cost pressure is increasing, which strengthens the case for cost-control programs; Daymark's BCBSRI program has reported lower admissions and spending. Global cancer medicine spending is projected to exceed $400 billion by 2028, while cancer has become the top health cost driver named by large employers, rising to 70% in 2027 from 58% the prior year.

A 2026 study of the 2025 BCBSRI program with Daymark found 10.4% fewer all-cause acute inpatient admissions and 8.1% lower total health care spending.

Daymark's national-scaling thesis is supported by its home-and-virtual care model and positive BCBSRI program results, and in September 2025 it announced a $20 million Series A to scale cancer care nationally. A study of the 2025 BCBSRI program with Daymark analyzed 5,432 patients across 20 oncology practices and found 10.4% fewer all-cause acute inpatient admissions and 8.1% lower health care spending. Daymark provides in-home and virtual care for symptoms, side effects, and urgent needs, with ongoing monitoring.

OncoHealth's Iris is a virtual supportive care service that provides 24/7 access to oncology-trained nurses, mental health therapists, and dietitians. Personalized Cancer Care offers 24/7 cancer guidance from a compassionate team of experts.

Daymark combines diagnostic workups with ongoing in-home and virtual cancer care, expediting workups through patient education and management of testing, imaging, biopsies, and prior authorizations while providing in-home and virtual care for symptoms, side effects, and urgent needs with ongoing monitoring. Its model delivers cancer care from the first abnormal finding through treatment and addresses clinical and non-clinical needs.

Other named programs provide virtual cancer guidance: OncoHealth's Iris is a virtual supportive-care service offering access to oncology nurses, mental-health therapists, and dietitians, and Thyme Care provides Personalized Cancer Care with 24/7 guidance from a team of experts.